Table 1.

Baseline characteristics of diabetic patients with good and poor glycemic control

	Good glycemic control group (n = 46)	Poor glycemic control group (n = 56)	P value
Male, n (%)	33 (71.7)	40 (71.4)	0.972
Age, years	61.83 ± 9.34	65.43 ± 6.73	0.026
Body mass index, Kg/m2	28.41 ± 2.59	28.16 ± 2.55	0.622
Cigarette smoking, n (%)	17 (37.0)	22 (56.4)	0.810
Hypertension, n (%)	30 (65.2)	45 (80.4)	0.085
Systolic blood pressure, mm Hg	135.35 ± 19.01	141.77 ± 18.69	0.090
Diastolic blood pressure, mm Hg	74.85 ± 10.69	77.82 ± 12.42	0.204
Fasting blood glucose, mmol/L	6.03 ± 0.81	6.90 ± 2.08	0.009
HbA1c, %	6.53 ± 0.31	8.13 ± 1.29	< 0.001
Serum creatinine, μmol/L	77.04 ± 15.21	78.70 ± 17.55	0.615
Serum uric acid, μmol/L	345.76 ± 79.73	345.98 ± 82.74	0.989
GFR, mL/min/1.73m2	86.83 ± 14.70	83.29 ± 14.47	0.225
Triglyceride, mmol/L	1.39 ± 0.84	1.92 ± 1.75	0.064
Total cholesterol, mmol/L	3.84 ± 0.88	3.89 ± 1.06	0.810
HDL cholesterol, mmol/L	1.23 ± 0.28	1.14 ± 0.25	0.100
LDL cholesterol, mmol/L	2.25 ± 0.80	2.21 ± 0.74	0.804
Apolipoprotein A, g/L	1.24 ± 0.16	1.17 ± 0.19	0.076
Apolipoprotein B, g/L	0.75 ± 0.33	0.75 ± 0.20	0.975
Lipoprotein (a), g/L	0.25 ± 0.27	0.33 ± 0.35	0.220
hsCRP, mg/L	1.18 (0.47–3.04)	2.16 (1.19 ~ 5.76)	0.002
Presence of CAD, n (%)	17 (37.0)	38 (67.9)	0.002
SYNTAX score	7.28 ± 10.54	15.88 ± 16.36	0.003
Gensini score	15.07 ± 21.03	48.99 ± 48.88	< 0.001
Medication, n (%)
ACE inhibitors/ARBs	25 (54.3)	27 (48.2)	0.538
β-blockers	28 (60.9)	40 (71.4)	0.260
Calcium channel blockers	13 (28.3)	14 (25.0)	0.710
Statins	43 (93.5)	49 (87.5)	0.312
Flow mediated dilation, %	6.94 ± 2.20	6.03 ± 2.08	0.036

Values are given as mean ± standard deviation (SD), median (25th–75th percentile) or number (percentage)

ACE angiotensin converting enzyme, ARB angiotensin receptor blocker, BUN blood urea nitrogen, CAD coronary artery disease, GFR glomerular filtration rate, HbA1c glycated hemoglobin, HDL high-density lipoprotein, hsCRP high-sensitivity C-reactive protein, LDL low-density lipoprotein